(19)
(11) EP 1 686 998 A1

(12)

(43) Date of publication:
09.08.2006 Bulletin 2006/32

(21) Application number: 04769658.8

(22) Date of filing: 18.10.2004
(51) International Patent Classification (IPC): 
A61K 31/505(2006.01)
A01K 67/027(2006.01)
C12N 15/11(2006.01)
A61K 38/46(2006.01)
C12N 5/06(2006.01)
(86) International application number:
PCT/IB2004/003396
(87) International publication number:
WO 2005/041972 (12.05.2005 Gazette 2005/19)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 31.10.2003 US 516213 P

(71) Applicant: Pfizer Products Inc.
Groton, Connecticut 06340 (US)

(72) Inventors:
  • BLACK, Shawn, Clive
    Groton, CT 06340 (US)
  • GIBBS, Earl, Michael
    Groton, CT 06340 (US)
  • MCNEISH, John, Douglas
    Groton, CT 06340 (US)

(74) Representative: Vanhee-Brossollet, Christine 
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) PHOSPHODIESTERASE 9 INHIBITION AS TREATMENT FOR OBESITY-RELATED CONDITIONS